Canine parvovirus (CPV) is a highly contagious and devastating virus that can affect all dogs, but unvaccinated dogs and puppies younger than 4 months old are the most at risk, resulting in a fatality rate greater than 90% if left untreated. In this episode of the VetFolio Voice podcast, Dr. Cassi and Dr. Fred Metzger discuss updates for the management of canine parvovirus. While vaccination can help prevent CPV, there have been no antiviral treatment options for dogs that become infected — until now. Canine Parvovirus Monoclonal Antibody (CPMA) is the first and only USDA-conditionally approved, one-dose parvovirus treatment. This exciting option could help to minimize the severity and course of the disease and decrease shedding of CPV. Dr. Metzger stresses the importance of client communication, especially when parvovirus is suspected in their pets. He explains how CPMA can be utilized as part of the treatment plan, and how it is administered, works, and positively impacts case outcomes, team morale and client relationships.

Immunotherapy in the Treatment and Management of Canine Parvovirus

Welcome to VetFolio Voice, the #1 Podcast Channel for the Veterinary Profession! New episodes every Thursday | Hosted by Dr. Cassi

The VetFolio Voice podcast series delivers weekly insights, industry news and useful information on topics that span the veterinary spectrum — from the latest medical breakthroughs to practice management tips. We make it easy to listen and learn on the go, whether during your commute, between clients in the clinic, or while tackling weekend chores!

VetFolio is an online educational platform powered by the NAVC, releasing new educational content weekly. Learn more at VetFolio.com.

Education

Training

Language Courses

Higher Education

K-12

Educational Technology

Dermatology conditions are among the most common reasons owners bring their pets into the veterinary clinic. These issues are also among the most difficult for you to treat, so it’s important to know your options. Tune into this informative VetFolio Voice podcast, as Dr. Dana Liska, a veterinary dermatologist with Zoetis, and Dr. Cassi highlight some key findings in a new study on adverse events with short-term steroid use in dogs. A few surprising findings debunk some of the myths and misperceptions about steroid side effects and have implications for pet owner communication on treatment options. Dr. Liska addresses the advantages of a chewable medication for canine allergic itch, including why pet owners prefer a chewable, how a chewable can lead to better compliance and decreased caregiver burden, and data around food allergy, speed of onset and transitioning patients onto the chewable.

Derm Updates: New Study on Steroid Use and What’s New with Chewable Treatments

In veterinary medicine, Addison’s disease – hypoadrenocorticism – has been called “the Great Imitator” because it can mimic so many other diseases. Patients often present with vague clinical signs or biochemical abnormalities, making it challenging to correctly diagnose. In fact, it’s been said that managing Addison’s is not nearly as difficult as making the diagnosis in the first place. This CE episode of the VetFolio Voice podcast discusses diagnosing Addison’s disease in veterinary patients with nebulous clinical signs or biochemical abnormalities. It also covers routine approaches to management and prognosis.
Want to earn CE credit for this podcast? Log into VetFolio to take the quiz and earn your CE credit.
https://www.vetfolio.com/courses/overcoming-the-great-imitator-addisons-disease-in-vet-med-podcast-quiz

Overcoming the Great Imitator, Addison’s Disease in Vet Med

Whatever she has accomplished — moving from Brazil to the U.S., transitioning into ZooMed, founding Vetahead — Dr. Lyla Proença has made a leap of faith and deep passion to pursue her dreams. In this episode of VetFolio Voice, Dr. Proença shares her journey of validating her veterinary diploma in the United States after moving from Brazil. She reveals the work, sweat and tears, and even how she considered changing career paths, which led her to ZooMed and the founding of VetAhead. Dr. Cassi and Dr. Proença discuss the core values that are the foundational support of VetAhead, the importance of access to knowledge for all veterinary professionals, and access to care for all species. They cover the importance of critical thinking when it comes to managing exotic species and the importance of recognizing and preserving the human animal bond with species beyond just dogs and cats.

Bakers, Baristas and the Journey to ZooMed

In this VetFolio Voice podcast episode, Dr. Cassi chats with Dr. Patty Lathan about the pathophysiology of feline diabetes mellitus and some exciting updates in the treatment of diabetes mellitus including sodium-glucose cotransporter 2 (SGLT2) inhibitors. They discuss the importance for veterinary practitioners to understand how these medications work, the recommendations for monitoring these patients and the adverse side effects and complications. They also explore some important updates on insulin, including the availability of glargine at a much lower price and upcoming clinical trials for a once weekly insulin formulation.
Want to earn CE from this episode? Be sure to log into VetFolio and take the quiz to qualify for your CE credit!
https://www.vetfolio.com/courses/advances-in-the-treatment-of-feline-diabetes-mellitus-podcast-quiz-1

Advances in the Treatment of Feline Diabetes Mellitus

Though rare, marijuana poisoning in pets is on the rise as the result of pet owners having increased legal access to marijuana and marijuana-infused products (both medicinal and recreational). Though the toxicity is typically mild, THC (delta-9 tetrahydrocannabinol) — the psychoactive compound in marijuana that makes people high — is toxic to pets and is no laughing matter. Tune in to this informative episode of the VetFolio Voice podcast to learn about the sources of THC toxicities, the clinical signs, diagnostics, and decontamination and treatment plans, as well as how to manage the rare case when the toxicity is severe.

Immunotherapy in the Treatment and Management of Canine Parvovirus

Download our free app to listen on your phone